On-Demand CME Videos
FC24: Skin Cancer Prognosis: The Tried and True and What’s New: An Online Activity
About
Skin Cancer Prognosis: The Tried and True and What's New: An Online Activity
This activity is supported by an educational grant from Castle Biosciences.
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
December 12, 2024
December 12, 2025
Learning Objectives
At the completion of this activity, participants should be better able to:
Define the role of gene expression profiling in the diagnostic workup of skin cancer
Identify strategies to incorporate gene expression profiling into clinical practice
Intended Audience
Faculty
Aaron Farberg, MD
Bare Dermatology
Baylor Scott & White Health System
Dallas, TX
Darrell Rigel, MD, MS
Clinical Professor of Dermatology
New York University
Grossman School of Medicine
New York, NY
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Speakers’ Bureau or Honoraria: Novartis, Sanofi Regeneron, SUN Pharma, Galderma, Castle Biosciences, Janssen, Ortho Dermatologics, Pfizer
Advisory Board: Castle Biosciences, Almirall
Grant/Research Support: Castle Biosciences
Consultant: Castle Biosciences
Speakers’ Bureau Honoraria: Beiersdorf, Castle Biosciences, Almirall, DermTech
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.